How Generic Drugs Control Healthcare Spending: A Complete Guide
Explore how generic drugs and biosimilars slash healthcare spending, the impact of the Hatch-Waxman Act, and the barriers preventing lower medication costs.
Apr 22 2026
Explore how generic drugs and biosimilars slash healthcare spending, the impact of the Hatch-Waxman Act, and the barriers preventing lower medication costs.
Apr 22 2026
Antitrust laws in generic drug markets prevent companies from blocking cheaper alternatives through pay-for-delay deals, sham patents, and product hopping. These tactics raise prices and hurt patient access. Enforcement is evolving globally, with the U.S., EU, and China taking stronger action.
Mar 19 2026